Literature DB >> 26171013

Cluster of differentiation 44- and octamer-binding transcription factor-4-positive stem-like osteosarcoma cells involved in tumor development.

Lan-Mei Liu1, Hong-Ai Sun2, Xiao Li1, Yang Chen1, Bao-Fu Wei3, Xiu-Ju Li4.   

Abstract

Osteosarcoma (OS) is an aggressive primary bone cancer that usually affects children and young adolescents. Previous studies have demonstrated the implications of a small sub-population of cancer stem cells on treatment failure and tumor recurrence. The present study analyzed the characteristic features of the stem-like cells within the human OS-55 cell line. It was identified that 2.3% of the OS-55 cells were cancer stem-like side population (SP) cells. Following treatment with verapamil, the population of SP cells was reduced to 0.7%. The sphere formation assay revealed that the OS cells were able to rapidly form tumor spheres (also known as sarcospheres). Immunofluorescence analysis identified that the OS-55 cells expressed the cluster of differentiation 44, octamer-binding transcription factor-3/4A and Nanog stem cell surface markers. The results of the present study suggest that, as with other tumors, OS also contains a sub-population of cancer stem-like cells, which may have important implications in cancer diagnosis and treatment.

Entities:  

Keywords:  adenosine triphosphate-binding cassette transporters; cancer stem cells; drug resistance; metastasis; tumor recurrence

Year:  2015        PMID: 26171013      PMCID: PMC4487167          DOI: 10.3892/ol.2015.3163

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

2.  Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors:  C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

3.  Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.

Authors:  Jin Su; Xin-Hua Xu; Qiao Huang; Ming-Qian Lu; Dao-Jun Li; Feng Xue; Fang Yi; Jing-Hua Ren; Yi-Pin Wu
Journal:  Arch Med Res       Date:  2011-01       Impact factor: 2.235

4.  Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.

Authors:  Liang Cheng
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

5.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Characterization of stem cell attributes in human osteosarcoma cell lines.

Authors:  Lin Wang; Paul Park; Chia-Ying Lin
Journal:  Cancer Biol Ther       Date:  2009-03-15       Impact factor: 4.742

9.  Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.

Authors:  Timothy A Damron; William G Ward; Andrew Stewart
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

10.  Recent translational research: stem cells as the roots of breast cancer.

Authors:  Chia-Cheng Chang
Journal:  Breast Cancer Res       Date:  2006-02-24       Impact factor: 6.466

View more
  2 in total

1.  Significance of cyclooxygenase-2, prostaglandin E2 and CD133 levels in sunitinib-resistant renal cell carcinoma.

Authors:  Lei Luo; Ye Liang; Xuemei Ding; Xiaocheng Ma; Guiming Zhang; Lijiang Sun
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

Review 2.  Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.

Authors:  Sara R Martins-Neves; Gabriela Sampaio-Ribeiro; Célia M F Gomes
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.